FRA/BRM (FRA/BRM)

Frankfurt Stock Exchange: FRA/BRM · EUR

€54.7

-0.27 (-0.5%)· Recorded snapshot

Market cap	112.8B
Revenue (ttm)	43.1B
Net income (ttm)	8.1B
EPS (ttm)	€4.08
P/E (trailing)	13.4x
P/E (forward)	10.1x
Dividend	€2.19 (4.01%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 43.1B
Net income (ttm): 8.1B
EPS (ttm): €4.08
P/E (trailing): 13.4x
P/E (forward): 10.1x
Market cap: 112.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.1

P25 n/aP50 n/aP75 n/a

Trailing P/E13.4

P25 n/aP50 n/aP75 n/a

ROE46.6

P25 n/aP50 n/aP75 n/a

ROIC21.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/BRM indicators

Market & fundamental data

Available fields

258

Groups with data

Currency

USD

Showing 258 of 258 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-29
Employees	32,500
Employees change	-1,600
Employees growth	-4.69%
Enterprise value	EUR 143B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1887
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US1101221083
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	1999-03-01
Last stock split type	Forward
Market cap	EUR 112.8B
Next earnings date	2026-10-29
Price	EUR 54.66
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	fra/BRM
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.47x
Average P/E ratio (3Y)	16.21x
Average P/E ratio (5Y)	18.92x
Earnings yield	7.46%
EV/Earnings	17.6x
EV/EBIT	10.08x
EV/EBITDA	8.19x
EV/FCF	14.28x
EV/Sales	3.24x
FCF / EV yield	7%
FCF yield	8.87%
Forward P/E	10.09x
Graham number	28.94715
Graham upside	-47.04%
Lynch fair value	EUR 20.63
Lynch upside	-62.26%
P/(FCF - SBC) ratio	11.84x
P/(OCF - SBC) ratio	10.54x
P/B ratio	5.78x
P/E ratio	13.4x
P/FCF ratio	11.27x
P/OCF ratio	10.09x
P/S ratio	2.62x
Price/EBITDA ratio	6.81x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.79%
EBITDA margin	38.49%
Effective tax rate	22.12%
FCF margin	22.68%
Gross margin	71.66%
Operating margin	31.79%
Pretax margin	24.21%
Profit margin	18.87%
Profit per employee	EUR 249,986
Profitable quarters	9
Profitable years	1
Revenue per employee	EUR 1.3M
ROA	10.72%
ROA (5Y)	6.51%
ROCE	22.67%
ROE	46.6%
ROE (5Y)	13.18%
ROIC	21.68%
ROIC (5Y)	14.63%
SBC / revenue	1.12%
Tax / revenue	5.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	82.74%
EPS growth (Q)	153.13%
EPS growth (QoQ)	23.66%
EPS growth 10Y	10.27%
EPS growth 3Y	6.51%
EPS growth quarters	4
EPS growth years	1
FCF growth	-21.53%
FCF growth (Q)	-13.16%
FCF growth (QoQ)	307.93%
FCF growth 3Y	2.19%
FCF growth 5Y	-0.43%
Gross profit growth	-0.04%
Gross profit growth (Q)	3.92%
Gross profit growth 3Y	0.16%
Gross profit growth 5Y	-0.04%
Net income growth	83.84%
Net income growth (Q)	153.21%
Net income growth (QoQ)	23.91%
Net income growth 3Y	5.24%
Net income growth quarters	4
Net income growth years	1
OCF growth	-19.62%
OCF growth (Q)	-13.38%
OCF growth (QoQ)	207.34%
OCF growth 10Y	25.24%
OCF growth 3Y	2.56%
OCF growth 5Y	0.44%
Operating income growth	23.89%
Operating income growth (Q)	8.06%
Operating income growth 3Y	21.58%
Operating income growth 5Y	13.64%
Revenue growth	3.11%
Revenue growth (Q)	5.74%
Revenue growth (QoQ)	12.92%
Revenue growth 10Y	10.81%
Revenue growth 3Y	2.87%
Revenue growth 5Y	2.08%
Revenue growth quarters	5
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.2B
Depreciation and amortization	EUR 3B
EBIT	EUR 13.7B
EBITDA	EUR 16.6B
EPS	EUR 4.08
Financing cash flow	EUR -10.2B
Free cash flow	EUR 10B
Free cash flow minus SBC	EUR 9.5B
Gross profit	EUR 30.9B
Income taxes	EUR 2.3B
Investing cash flow	EUR -4.3B
Net borrowing	EUR -5.8B
Net cash flow	EUR -3.4B
Net income	EUR 8.1B
Operating cash flow minus SBC	EUR 10.7B
Operating income	EUR 13.7B
Revenue	EUR 43.1B
Stock-based compensation	EUR 484M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.59
Book value per share	EUR 9.56
Debt / EBITDA	2.34
Debt / equity	2.02
Debt / FCF	3.94
Goodwill	EUR 19.5B
Interest coverage	9.07
Long-term assets	EUR 51.1B
Long-term liabilities	EUR 40.4B
Net cash (debt)	EUR -29.4B
Net cash / market cap	-26.05%
Net debt / EBITDA	1.77
Net debt / equity	1.5
Net debt / FCF	2.94
Piotroski F-Score	7
Property, plant and equipment	EUR 8.3B
Shareholders' equity	EUR 19.5B
Tangible book value	EUR -14.7B
Tangible book value per share	EUR -7.20
Total assets	EUR 76.7B
Total cash	EUR 9.7B
Total debt	EUR 39.4B
Total liabilities	EUR 57.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	EUR 25.7B
Current liabilities	EUR 16.8B
Current ratio	1.53
Inventory turnover	5.09
Net working capital	EUR 76.2M
Quick ratio	1.29
Working capital	EUR 8.7B
Working capital turnover	5.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.47%
Dividend growth	-1.33%
Dividend growth (10Y)	4.79%
Dividend growth (3Y)	1.02%
Dividend growth (5Y)	5.82%
Dividend growth years	4
Dividend payment date	2026-11-02
Dividend payment years	30
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.19
Dividend yield	4.01%
Ex-dividend date	2026-10-02
Last dividend	EUR 0.56
Payout ratio	54.89%
Shareholder yield	3.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	20.98%
10Y return CAGR	5.61%
10Y total return	72.61%
150-day SMA	EUR 52.21
15Y price change	138.59%
15Y return CAGR	9.6%
15Y total return	295.39%
1D price change	-0.49%
1M price change	-0.13%
1M total return	0.9%
1W price change	3.19%
1W total return	3.19%
1Y price change	44.74%
1Y return CAGR	51.25%
1Y total return	51.21%
20-day SMA	EUR 53.53
200-day SMA	EUR 51.64
20Y price change	184.1%
20Y return CAGR	9.41%
20Y total return	503.93%
3M price change	0.4%
3M total return	1.44%
3Y price change	8.88%
3Y return CAGR	7.81%
3Y total return	25.31%
50-day SMA	EUR 55.08
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 60.64
52-week high date	2026-08-03
52-week low	EUR 36.65
52-week low date	2025-10-30
5Y price change	9.54%
5Y return CAGR	6.13%
5Y total return	34.63%
6M price change	9.43%
6M total return	11.81%
All-time high	EUR 84.30
All-time high date	2000-11-29
All-time low	EUR 12.45
All-time low date	2008-10-10
Average true range (ATR)	EUR 1.11
Average volume	261.4
Change from 52-week high	-9.86%
Change from 52-week low	49.14%
Change from all-time high	-35.16%
Change from all-time low	339.04%
Change from open	-0.73%
Day's gap	0.24%
High price	EUR 55.06
Low price	EUR 54.66
Monthly RSI	57.18
Open price	EUR 55.06
Position in 52-week range	0%
Previous close	EUR 54.93
Price vs 150-day SMA	4.69%
Price vs 20-day SMA	2.12%
Price vs 200-day SMA	5.85%
Price vs 50-day SMA	-0.76%
Relative volume	1.37
RSI	52.52
Sharpe ratio	1.56
Sharpe ratio (3Y)	0.32
Sharpe ratio (5Y)	0.17
Sortino ratio	2.69
Sortino ratio (3Y)	0.69
Sortino ratio (5Y)	0.47
Volume	0
Weekly RSI	55.21
YTD price change	19.9%
YTD total return	25.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2B
Shares change (QoQ)	0.05%
Shares change (YoY)	0.47%
Shares held by insiders	0.05%
Shares held by institutions	83.01%
Short ratio	4.3 days

Deeper analysis on FRA/BRM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/BRM report

Is a complete FRA/BRM research report available?

No complete published report is available for fra/BRM (FRA/BRM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/BRM (FRA/BRM)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/BRM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/BRM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/BRM

Frequently asked questions